Evidence map›Paper›PMID 25887883›Full record

ArticleBMC genetics2015

Genomic architecture of potato resistance to Synchytrium endobioticum disentangled using SSR markers and the 8.3k SolCAP SNP genotyping array.

Jude Eijkeme Obidiegwu, Rena Sanetomo, Kerstin Flath, Eckhard Tacke, Hans-Reinhard Hofferbert, Andrea Hofmann, Birgit Walkemeier, Christiane Gebhardt

Abstract read
In one paragraph

Article in BMC genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. A Hitchhiker's guide to the potato wart disease resistance galaxy.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Novel gene Sen2 conferring broad-spectrum resistance to Synchytrium endobioticum mapped to potato chromosome XI.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2018
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jude Eijkeme ObidiegwuDepartment of Plant Breeding and Genetics, Max-Planck-Institute for Plant Breeding Research, Cologne, Germany. Jude.Obidiegwu@hutton.ac.uk.
Rena SanetomoDepartment of Plant Breeding and Genetics, Max-Planck-Institute for Plant Breeding Research, Cologne, Germany. sanetomo@obihiro.ac.jp.
Kerstin FlathJulius Kühn Institute, Federal Research Centre for Cultivated Plants, Kleinmachnow, Germany. Kerstin.Flath@jki.bund.de.
Eckhard TackeBioplant GmbH, Ebstorf, Germany. Tacke@bioplant.de.
Hans-Reinhard HofferbertBöhm-Nordkartoffel Agrarproduktion GbR, Ebstorf, Germany. HRHofferbert@bna-kartoffel.de.
Andrea HofmannDepartment of Genomics, Life & Brain Center, Institute of Human Genetics, University of Bonn, Bonn, Germany. andrea.hofmann@uni-bonn.de.
Birgit WalkemeierDepartment of Plant Breeding and Genetics, Max-Planck-Institute for Plant Breeding Research, Cologne, Germany. walkemei@mpipz.mpg.de.
Christiane GebhardtDepartment of Plant Breeding and Genetics, Max-Planck-Institute for Plant Breeding Research, Cologne, Germany. gebhardt@mpipz.mpg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe soil borne, obligate biotrophic fungus Synchytrium endobioticum causes tumor-like tissue proliferation (wart) in potato tubers and thereby considerable crop damage. Chemical control is not effective and unfriendly to the environment. S. endobioticum is therefore a quarantined pathogen. The emergence of new pathotypes of the fungus aggravate this agricultural problem. The best control of wart disease is the cultivation of resistant varieties. Phenotypic screening for resistant cultivars is however time, labor and material intensive. Breeding for resistance would therefore greatly benefit from diagnostic DNA markers that can be applied early in the breeding cycle. The prerequisite for the development of diagnostic DNA markers is the genetic dissection of the factors that control resistance to S. endobioticum in various genetic backgrounds of potato.

resultsProgeny of a cross between a wart resistant and a susceptible tetraploid breeding clone was evaluated for resistance to S. endobioticum pathotypes 1, 2, 6 and 18 most relevant in Europe. The same progeny was genotyped with 195 microsatellite and 8303 single nucleotide polymorphism (SNP) markers. Linkage analysis identified the multi-allelic locus Sen1/RSe-XIa on potato chromosome XI as major factor for resistance to all four S. endobioticum pathotypes. Six additional, independent modifier loci had smaller effects on wart resistance. Combinations of markers linked to Sen1/RSe-XIa resistance alleles with one to two additional markers were sufficient for obtaining high levels of resistance to S. endobioticum pathotypes 1, 2, 6 and 18 in the analyzed genetic background.

conclusionsPotato resistance to S. endobioticum is oligogenic with one major and several minor resistance loci. It is composed of multiple alleles for resistance and susceptibility that originate from multiple sources. The genetics of resistance to S. endobioticum varies therefore between different genetic backgrounds. The DNA markers described in this paper are the starting point for pedigree based selection of cultivars with high levels of resistance to S. endobioticum pathotypes 1, 2, 6 and 18.

Indexed as

ChytridiomycotaGenome, PlantMicrosatellite RepeatsPolymorphism, Single NucleotideDisease ResistanceGenes, PlantGenome-Wide Association StudyGenotyping TechniquesHaplotypesModels, GeneticMultigene FamilyPhenotypePlant DiseasesQuantitative Trait LociSolanum tuberosum

Identifiers

PMID25887883
PMCPMC4407358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.